Steven Siegel, M.D. Ph.D

 Steven Siegel received his MD and PhD in Neurobiology at the Mount Sinai School of Medicine in 1996 after completing an undergraduate degree in Neuroscience at Colgate University in 1986. He later completed residency in Psychiatry and a Fellowship in Neuropsychiatry at the University of Pennsylvania before joining the faculty in 2001. He is currently the Director of the Translational Neuroscience Program in Department of Psychiatry and Director of the Clinical Neurosciences Training Program for the Perelman School of Medicine at the University of Pennsylvania.  He is also a practicing psychiatrist specializing in the treatment of Schizophrenia.  His laboratory investigates the neurobiology of schizophrenia, autism, drug abuse and nicotine dependence using animal models to evaluate EEG and event related brain activity, combined with behavioral and molecular studies in mice. Additionally, his laboratory has established new methods for the treatment of Schizophrenia using biodegradable long-term delivery systems. The methods and technologies developed in his group are also being extended to the treatment of Parkinson's Disease.